Delaware Crossing Investor Group Overview
- Investor Type
-
Angel Group
- Status
-
Active
- Professionals
-
3
- Investments
-
74
- Portfolio
-
22
- Exits
-
31
Delaware Crossing Investor Group General Information
Company Description
Delaware Crossing Investor Group is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and growing companies. The firm is a membership organization of investors who manage the investment process and serve as the board of directors of portfolio companies. The firm is based in Warrington, Pennsylvania, and was founded in 2005.
Business Details
Website
www.delawarecrossing.orgYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 2700 Kelly Road
- Suite 300
- Warrington, PA 18976
- United States
Delaware Crossing Investor Group Investments (74)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| KaloCyte | 02-Jun-2025 | Later Stage VC | Biotechnology | Pre-Clinical Trials | ||
| Vytala | 19-Sep-2024 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Measure Studio | 21-Apr-2023 | Business/Productivity Software | Generating Revenue | |||
| Gilson (Recreational Goods) | 03-Oct-2022 | Recreational Goods | Generating Revenue | |||
| SunRay Scientific | 08-Sep-2022 | Industrial Supplies and Parts | Generating Revenue | |||
| Medcura | 12-Aug-2021 | Surgical Devices | Product Development | |||
| Myota | 10-Jun-2021 | Network Management Software | Generating Revenue | |||
| Strados Labs | 01-Nov-2020 | Monitoring Equipment | Generating Revenue | |||
| Medcura | 21-Sep-2020 | Later Stage VC | Surgical Devices | Product Development | ||
| Pledge It | 09-Jul-2020 | Seed Round | Other Financial Services | Generating Revenue |
Delaware Crossing Investor Group Exits (31)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Grassroots Unwired | 01-Feb-2026 | Secondary Transaction - Private | |
| OnlySky | 01-Feb-2026 | ||
| Tobly | 01-Feb-2026 | ||
| MMGuardian | 01-Oct-2023 | ||
| Holganix | 01-Jul-2023 | ||
| Hulafrog | 12-Jan-2023 | ||
| Lia Diagnostics | 13-Oct-2022 | ||
| Starr Life Sciences | 01-Nov-2021 | ||
| Immunome (acquired in 2023) | 02-Oct-2020 | IPO | |
| Squareknot | 01-Jul-2020 | Out of Business |
Delaware Crossing Investor Group Investments by Industry, Year, and Region
Delaware Crossing Investor Group Co-Investors (35)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Jumpstart NJ Angel Network | 2 |
|
|
||
| Robin Hood Ventures |
|
|
|||
| Golden Seeds |
|
|
|||
| Tech Council Ventures |
|
|
|||
| Ulu Ventures |
|
|
Delaware Crossing Investor Group FAQs
-
What is Delaware Crossing Investor Group?
Delaware Crossing Investor Group is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and growing companies.
-
When was Delaware Crossing Investor Group founded?
Delaware Crossing Investor Group was founded in 2005.
-
Where is Delaware Crossing Investor Group headquartered?
Delaware Crossing Investor Group is headquartered in Warrington, PA.
-
How many investments has Delaware Crossing Investor Group made?
Delaware Crossing Investor Group has made 74 investments.
-
What has Delaware Crossing Investor Group invested in?
Delaware Crossing Investor Group has made numerous investments in companies like KaloCyte, Vytala, and Measure Studio within the Biotechnology, Pharmaceuticals and Biotechnology, and Business/Productivity Software industries.
-
What has Delaware Crossing Investor Group invested in recently?
Delaware Crossing Investor Group's latest investment was on 02-Jun-2025 in KaloCyte, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process